We serve Chemical Name:2-(Chloromethyl)thiazole CAS:3364-78-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-(Chloromethyl)thiazole
CAS.NO:3364-78-1
Synonyms:2-(Chloromethyl)-1,3-thiazole;Thiazole, 2-(chloromethyl)-
Molecular Formula:C4H4ClNS
Molecular Weight:133.599
HS Code:2934100090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:181.6±23.0 °C at 760 mmHg
Density:1.3±0.1 g/cm3
Index of Refraction:1.564
PSA:41.13000
Exact Mass:132.975296
LogP:1.33
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-(Chloromethyl)-1,3-thiazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Thiazole, 2-(chloromethyl)- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(Chloromethyl)-1,3-thiazole Use and application,Thiazole, 2-(chloromethyl)- technical grade,usp/ep/jp grade.
Related News: Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world. 2-(Chloromethyl)thiazole manufacturer The findings were published June 14 in the journal Nature Aging. 2-(Chloromethyl)thiazole supplier However, compared with the 60-70% refinement rate in developed economies such as North America, Western Europe, and Japan, China is still only equivalent to the level of the United States in the 1980s. There is still a lot of room for improvement in China’s refinement rate. period. 2-(Chloromethyl)thiazole vendor Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world. 2-(Chloromethyl)thiazole factory Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.
